Manufacturer of Controlled Substances; Notice of Application, 47029 [2010-19078]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 149 / Wednesday, August 4, 2010 / Notices
Consent Decree Library at the stated
address.
DEPARTMENT OF LABOR
Office of the Secretary
Maureen Katz,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
Submission for OMB Review;
Comment Request
July 29, 2010.
[FR Doc. 2010–19102 Filed 8–3–10; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on January 27, 2009,
Johnson Matthey Pharma Services, 70
Flagship Drive, North Andover,
Massachusetts 01845, made application
to the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in schedule
II:
Drug
Schedule
mstockstill on DSKH9S0YB1PROD with NOTICES
Amphetamine (1100) ....................
Hydrocodone (9193) .....................
Methylphenidate (1724) ................
II
II
II
The company plans to utilize this
facility to manufacture small quantities
of the listed controlled substances in
bulk and to conduct analytical testing in
support of the company’s primary
manufacturing facility in West Deptford,
New Jersey. The controlled substances
manufactured in bulk at this facility will
be distributed to the company’s
customers.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than October 4, 2010.
Dated: July 23, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–19078 Filed 8–3–10; 8:45 am]
BILLING CODE 4410–09–P
VerDate Mar<15>2010
16:26 Aug 03, 2010
Jkt 220001
The Department of Labor (DOL)
hereby announces the submission of the
following public information collection
request (ICR) to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995
(Pub. L. 104–13, 44 U.S.C. chapter 35).
A copy of this ICR, with applicable
supporting documentation; including,
among other things, a description of the
likely respondents, proposed frequency
of response, and estimated total burden
may be obtained from the RegInfo.gov
Web site at https://www.reginfo.gov/
public/do/PRAMain or by contacting
Linda Watts Thomas on 202–693–4223
(this is not a toll-free number) e-mail
mail to: DOL_PRA_PUBLIC@dol.gov.
Interested parties are encouraged to
send comments to the Office of
Information and Regulatory Affairs,
Attn: OMB Desk Officer for the
Department of Labor—Office of
Workers’ Compensation Programs
(OWCP), Room 10235, Washington, DC
20503, Telephone: 202–395–7316/Fax
202–395–5806 (these are not toll-free
numbers), E-mail:
OIRA_submission@omb.eop.gov within
30 days from the date of this publication
in the Federal Register. In order to
ensure the appropriate consideration,
comments should reference the
applicable OMB Control Number (see
below).
The OMB is particularly interested in
comments which:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
PO 00000
Frm 00131
Fmt 4703
Sfmt 4703
47029
Agency: Office of Workers’
Compensation Programs.
Type of Review: Revision of a
currently approved collection.
Title of Collection: Energy Employees
Occupational Illness Compensation Act
Forms (various).
OMB Control Number: 1240–0002.
Form Numbers: EE–1, EE–2, EE–3,
EE–4, EE–7, EE–8, EE–9, EE–10, EE–
11A, EE–11B, EE–12, EE–13, EE–16 and
EE–20.
Estimated Number of Respondents:
57,175.
Estimated Total Annual Burden
Hours: 21,729.
Estimated Total Hour Burden Cost
(operating/maintaining): $22,781.37.
Affected Public: Individuals or
households; Business or other for-profit.
Description: The Office of Workers’
Compensation Programs (OWCP) is the
primary agency responsible for the
administration of the Energy Employees
Occupational Illness Compensation
Program Act of 2000, as amended
(EEOICPA or Act), 42 U.S.C. 7384 et seq.
The Act provides for timely payment of
compensation to covered employees
and, where applicable, survivors of such
employees, who sustained either
‘‘occupational illnesses’’ or ‘‘covered
illnesses’’ incurred in the performance
of duty for the Department of Energy
and certain of its contractors and
subcontractors. The Act sets forth
eligibility criteria for claimants for
compensation under Part B and Part E
of the Act, and outlines the various
elements of compensation payable from
the Fund established by the Act. The
information collections in this ICR
collect demographic, factual and
medical information needed to
determine entitlement to benefits under
the EEOICPA.
For additional information, see
related notice published in the Federal
Register on March 8, 2010 (Vol. 75 page
10504).
Dated: July 26, 2010.
Linda Watts Thomas,
Acting Departmental Clearance Officer.
[FR Doc. 2010–19112 Filed 8–3–10; 8:45 am]
BILLING CODE 4510–CR–P
NATIONAL ARCHIVES AND RECORDS
ADMINISTRATION
Agency Information Collection
Activities: Proposed Collection;
Comment Request
National Archives and Records
Administration (NARA).
ACTION: Notice.
AGENCY:
E:\FR\FM\04AUN1.SGM
04AUN1
]]>Agencies
[Federal Register Volume 75, Number 149 (Wednesday, August 4, 2010)]
[Notices]
[Page 47029]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-19078]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on January 27, 2009, Johnson
Matthey Pharma Services, 70 Flagship Drive, North Andover,
Massachusetts 01845, made application to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the
basic classes of controlled substances listed in schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Amphetamine (1100)......................... II
Hydrocodone (9193)......................... II
Methylphenidate (1724)..................... II
------------------------------------------------------------------------
The company plans to utilize this facility to manufacture small
quantities of the listed controlled substances in bulk and to conduct
analytical testing in support of the company's primary manufacturing
facility in West Deptford, New Jersey. The controlled substances
manufactured in bulk at this facility will be distributed to the
company's customers.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than October 4, 2010.
Dated: July 23, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-19078 Filed 8-3-10; 8:45 am]
BILLING CODE 4410-09-P
